Published in Clin Exp Med on January 30, 2009
A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia. Blood (2014) 1.80
L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase. Cancer (2010) 1.69
Best Practices in Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia: A Focus on Asparaginase. J Adolesc Young Adult Oncol (2015) 0.89
Update on the Use of l-Asparaginase in Infants and Adolescent Patients with Acute Lymphoblastic Leukemia. Clin Med Insights Oncol (2014) 0.87
Allergic reactions and antiasparaginase antibodies in children with high-risk acute lymphoblastic leukemia: A children's oncology group report. Cancer (2015) 0.80
Asparaginase-associated toxicity in children with acute lymphoblastic leukemia. Leuk Lymphoma (2015) 0.77
Rationale for a pediatric-inspired approach in the adolescent and young adult population with acute lymphoblastic leukemia, with a focus on asparaginase treatment. Hematol Rep (2014) 0.77
Desensitization protocol should not be used in acute lymphoblastic leukemia patients with silent inactivation of PEGasparaginase. Haematologica (2014) 0.75
Asparaginase pharmacokinetics and implications of therapeutic drug monitoring. Leuk Lymphoma (2015) 0.75
Comparative immunogenicity and structural analysis of epitopes of different bacterial L-asparaginases. BMC Cancer (2016) 0.75
The use of Erwinia asparaginase for adult patients with acute lymphoblastic leukemia after pegaspargase intolerance. Leuk Res (2016) 0.75
Childhood leukemias. N Engl J Med (1995) 2.43
Asparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia: Children's Cancer Group Study CCG-1961. J Pediatr Hematol Oncol (2004) 1.80
Use of L-asparaginase in childhood ALL. Crit Rev Oncol Hematol (1998) 1.69
Comparative pharmacokinetic studies of three asparaginase preparations. J Clin Oncol (1993) 1.65
Pharmacological and clinical evaluation of L-asparaginase in the treatment of leukemia. Crit Rev Oncol Hematol (2006) 1.37
Cancer therapy with chemically modified enzymes. I. Antitumor properties of polyethylene glycol-asparaginase conjugates. Cancer Biochem Biophys (1984) 1.29
Evaluation of immunologic crossreaction of antiasparaginase antibodies in acute lymphoblastic leukemia (ALL) and lymphoma patients. Leukemia (2003) 1.18
Pegylated asparaginase (Oncaspar) in children with ALL: drug monitoring in reinduction according to the ALL/NHL-BFM 95 protocols. Br J Haematol (2000) 1.00
Anti-asparaginase antibodies following E. coli asparaginase therapy in pediatric acute lymphoblastic leukemia. Leukemia (1998) 1.00
Antibody response to Escherichia coli L-asparaginase. Prognostic significance and clinical utility of antibody measurement. Am J Pediatr Hematol Oncol (1986) 0.95
Antibody formation during intravenous and intramuscular therapy with Erwinia asparaginase. Med Pediatr Oncol (2002) 0.94
Factors which may influence the effectiveness of L-asparaginases as tumor inhibitors. Br J Cancer (1968) 0.93
Reduction in immunogenicity and clearance rate of Escherichia coli L-asparaginase by modification with monomethoxypolyethylene glycol. J Pharmacol Exp Ther (1981) 0.87
An open-label, multicenter study of polyethylene glycol-L-asparaginase for the treatment of acute lymphoblastic leukemia. Cancer (1995) 0.87
Development of anti-asparaginase antibodies in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer (2004) 0.84
Characterization of polyethylene glycol-modified L-asparaginase from Escherichia coli and its application to therapy of leukemia. Jpn J Cancer Res (1986) 0.79
The anti-asparagines antibodies correlate with L-asparagines activity and may affect clinical outcome of childhood acute lymphoblastic leukemia. Leuk Lymphoma (2007) 1.68
Polymorphism within the glutathione S-transferase P1 gene is associated with increased susceptibility to childhood malignant diseases. Pediatr Blood Cancer (2004) 1.43
Like-triple diabetes as first manifestation of MODY2 in an overweight teenager with transient multiple antibodies. Diabetes Care (2014) 1.39
Additional genetic risk factor for death in children with acute lymphoblastic leukemia: a common polymorphism of the MTHFR gene. Pediatr Blood Cancer (2009) 1.38
Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia. Eur J Haematol (2004) 1.25
Selective loss of fine tuning of Gq/11 signaling by RGS2 protein exacerbates cardiomyocyte hypertrophy. J Biol Chem (2005) 1.25
Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11. Nat Clin Pract Neurol (2007) 1.22
Efficacy and safety of sulfonylurea use in permanent neonatal diabetes due to KCNJ11 gene mutations: 34-month median follow-up. Diabetes Technol Ther (2010) 1.03
Role of 657del5 NBN mutation and 7p12.2 (IKZF1), 9p21 (CDKN2A), 10q21.2 (ARID5B) and 14q11.2 (CEBPE) variation and risk of childhood ALL in the Polish population. Leuk Res (2011) 0.99
Serum levels of vascular endothelial growth factor and basic fibroblastic growth factor in children with hemangiomas and vascular malformations--preliminary report. Pediatr Dermatol (2009) 0.97
Transfer to sulphonylurea therapy in adult subjects with permanent neonatal diabetes due to KCNJ11-activating [corrected] mutations: evidence for improvement in insulin sensitivity. Diabetes Care (2007) 0.96
The first case report of sulfonylurea use in a woman with permanent neonatal diabetes mellitus due to KCNJ11 mutation during a high-risk pregnancy. J Clin Endocrinol Metab (2010) 0.94
[Treatment results of children with neuroblastoma: report of Polish Pediatric Solid Tumor Group]. Przegl Lek (2010) 0.92
Vitamin D receptor gene variability as a factor influencing bone mineral density in pediatric patients. Mol Biol Rep (2012) 0.90
Genotoxicity of idarubicin and its modulation by vitamins C and E and amifostine. Chem Biol Interact (2002) 0.89
Islet-specific antibody seroconversion in patients with long duration of permanent neonatal diabetes caused by mutations in the KCNJ11 gene. Diabetes Care (2007) 0.89
Mutations in the ABCC8 (SUR1 subunit of the K(ATP) channel) gene are associated with a variable clinical phenotype. Clin Endocrinol (Oxf) (2008) 0.89
EURO-WABB: an EU rare diseases registry for Wolfram syndrome, Alström syndrome and Bardet-Biedl syndrome. BMC Pediatr (2013) 0.88
Evidence against RAB40AL being the locus for Martin-Probst X-linked deafness-intellectual disability syndrome. Hum Mutat (2014) 0.87
Cytoprotective effect of amifostine in the treatment of childhood neoplastic diseases--a clinical study including the pharmacoeconomic analysis. Pharmacol Rep (2006) 0.86
Atypical phenotypic features among carriers of a novel Q248X nonsense mutation in the HNF1B gene. Endokrynol Pol (2015) 0.86
Development of anti-asparaginase antibodies in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer (2004) 0.84
[Optimization of monogenic diabetes screening programme--initial report on recruitment efficacy of the TEAM project]. Pediatr Endocrinol Diabetes Metab (2010) 0.83
Influence of interleukin IL-2 and IL-12 + IL-18 on surface expression of immunoglobulin-like receptors KIR2DL1, KIR2DL2, and KIR3DL2 in natural killer cells. Mediators Inflamm (2006) 0.81
Multicenter cross-sectional analysis of values of glycated haemoglobin (HbA1c) in Polish children and adolescents with long-term type 1 diabetes in Poland: PolPeDiab study group. Pediatr Endocrinol Diabetes Metab (2012) 0.81
Circadian blood pressure variation in normotensive type 2 diabetes patients and angiotensin converting enzyme polymorphism. Diabetes Res Clin Pract (2008) 0.81
HDL cholesterol as a diagnostic tool for clinical differentiation of GCK-MODY from HNF1A-MODY and type 1 diabetes in children and young adults. Clin Endocrinol (Oxf) (2011) 0.81
Distribution of allelic variants of functional C3435T polymorphism of drug transporter MDR1 gene in a sample of Polish population. Pol J Pharmacol (2003) 0.81
FOXP3, IL-10, and TGF-β genes expression in children with IgE-dependent food allergy. J Clin Immunol (2010) 0.81
Are zinc transporter type 8 antibodies a marker of autoimmune thyroiditis in non-obese adults with new-onset diabetes? Eur J Endocrinol (2014) 0.81
[Characteristics of extracranial malignant germ cell tumours in two age groups of children (0-10 and 10-18 years). Multicentre experiences]. Med Wieku Rozwoj (2011) 0.81
Abdominal obesity, metabolic syndrome in type 1 diabetic children and adolescents. Pediatr Endocrinol Diabetes Metab (2009) 0.81
Dunnigan-type familial partial lipodystrophy associated with the heterozygous R482W mutation in LMNA gene - case study of three women from one family. Endokrynol Pol (2013) 0.80
[Insulin glargine improves fasting blood glucose levels in prepubertal children with unsatisfactorily controlled type 1 diabetes]. Pediatr Endocrinol Diabetes Metab (2007) 0.80
[Helicobacter pylori infection and its metabolic consequences in children and adolescents with type 1 diabetes mellitus]. Med Wieku Rozwoj (2007) 0.80
Perinatal palliative care: barriers and attitudes of neonatologists and nurses in Poland. ScientificWorldJournal (2013) 0.80
Assessment of insulin sensitivity in adults with permanent neonatal diabetes mellitus due to mutations in the KCNJ11 gene encoding Kir6.2. Rev Diabet Stud (2006) 0.79
Blood pressure in children and adolescents with type 1 diabetes mellitus--the influence of body mass index and fat mass. Pediatr Endocrinol Diabetes Metab (2009) 0.79
Increased risk of type 1 diabetes in Polish children - association with INS-IGF2 5'VNTR and lack of association with HLA haplotype. Endokrynol Pol (2011) 0.79
[Glucokinase gene mutation as a causative factor of permanent neonatal diabetes mellitus]. Pediatr Endocrinol Diabetes Metab (2012) 0.79
Polymorphism of the thymidylate synthase gene and risk of relapse in childhood ALL. Leuk Res (2011) 0.79
Human leukocyte antigen-G polymorphisms influence the clinical outcome in diffuse large B-cell lymphoma. Genes Chromosomes Cancer (2015) 0.78
Effect of the IP10 (CXCL10) and HLA genotype on the risk of type 1 diabetes in children. Pediatr Endocrinol Diabetes Metab (2011) 0.78
Assessment of interleukin-6, interleukin-8 and interleukin-18 count in the serum of IUGR newborns. J Matern Fetal Neonatal Med (2013) 0.78
[Epidemiology and clinical course of diabetic ketoacidosis in children and adolescents with type 1 diabetes mellitus]. Pediatr Endocrinol Diabetes Metab (2013) 0.78
[Prevalence of thyroid antibodies (TPO and ATG) at the onset of type 1 diabetes mellitus in children treated in two diabetes centres in Łódź and Kielce]. Med Wieku Rozwoj (2003) 0.78
Serum tumor necrosis factor-α and interleukin-10 levels as markers to predict outcome of patients with chronic lymphocytic leukemia in different risk groups defined by the IGHV mutation status. Arch Immunol Ther Exp (Warsz) (2012) 0.78
MIG (CXCL9), IP-10 (CXCL10) and I-TAC (CXCL11) concentrations after nasal allergen challenge in patients with allergic rhinitis. Arch Med Sci (2013) 0.78
Genotyping of p53 codon 175 in colorectal cancer. Med Sci Monit (2003) 0.78
[Genotyping and minimal residual disease study in children with acute myeloid leukemia: preliminary results]. Przegl Lek (2010) 0.78
Induction of caspase 3 and modulation of some apoptotic genes in human acute promyelocytic leukemia HL-60 cells by carboplatin with amifostine. Pol J Pharmacol (2003) 0.78
[Factors involved in ketoacidosis at the onset of type 1 diabetes in childhood]. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw (2003) 0.78
[Polymorphism I/D of the angiotensin-converting enzyme gene and disturbance of blood pressure in type 1 diabetic children and adolescents]. Przegl Lek (2006) 0.78
Who receives home-based perinatal palliative care: experience from Poland. Biomed Res Int (2013) 0.78
Amifostine differentially modulates DNA damage evoked by idarubicin in normal and leukemic cells. Leuk Res (2002) 0.78
[Role of IFN-gamma and TNF-alpha in etiology of nasal polyps--initial studies]. Otolaryngol Pol (2008) 0.78
Induction of caspase 3 activity, bcl-2 bax and p65 gene expression modulation in human acute promyelocytic leukemia HL-60 cells by doxorubicin with amifostine. Pharmacol Rep (2005) 0.77
[Analysis of microvascular density and the expression of vascular-endothelial growth factor (VEGF) and its membrane receptor Flk-1 in neuroblastoma]. Med Wieku Rozwoj (2007) 0.77
[ACE gene polymorphism and renal scarring in children with urinary tract infection and vesicoureteric reflux: preliminary results]. Pol Merkur Lekarski (2003) 0.77
[Factors affecting C-peptide level during the first year of type 1 diabetes in children]. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw (2004) 0.77
Is the SIOP-2001 Classification of Renal Tumors of Childhood accurate with regard to prognosis? A problem revisited. Arch Med Sci (2012) 0.77
First one-step nucleic acid amplification testing in papillary thyroid cancer lymph nodes - a comparison with histopathology and real-time PCR. Endokrynol Pol (2014) 0.77
Non-coding glucometers among pediatric patients with diabetes: looking for the target population and an accuracy evaluation of no-coding personal glucometer. Pediatr Endocrinol Diabetes Metab (2011) 0.77
The 5'VNTR proinsulin gene (INS) polymorphism and the functional reserve of β cells in the intravenous glucose tolerance test. Pediatr Endocrinol Diabetes Metab (2011) 0.77
Metabolic syndrome components among children born small for gestational age: analysis of the first decade of life. Pediatr Endocrinol Diabetes Metab (2010) 0.77
Genetic testing for monogenic diabetes using targeted next-generation sequencing in patients with maturity-onset diabetes of the young. Pol Arch Med Wewn (2015) 0.76
Electrogastrography in children and adolescents with type 1 diabetes: weak correlation with metabolic control parameters. Acta Paediatr (2006) 0.76
Secondary acute monocytic leukemia positive for 11q23 rearrangement in Nijmegen breakage syndrome. Pediatr Blood Cancer (2014) 0.76
TEL/JAK2 tyrosine kinase inhibits DNA repair in the presence of amifostine. Acta Biochim Pol (2002) 0.76
Efficacy of metabolic and psychological screening for mood disorders among children with type 1 diabetes. Diabetes Care (2012) 0.76
Frequency of the E23K polymorphism of the KCNJ11 gene in children born small for gestational age and its influence on auxological and metabolic parameters in the prepubertal period. J Pediatr Endocrinol Metab (2013) 0.76
[Insulin resistance in type 1 diabetic children and adolescents -- a simplified method of estimation]. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw (2006) 0.76
Familial partial lipodystrophy as differential diagnosis of polycystic ovary syndrome. Endokrynol Pol (2015) 0.76
[Urinary tract infections in children under three years of age]. Pol Merkur Lekarski (2003) 0.75
[Polymorphism at the glutathione S-transferase pi locus as a risk factor for ifosfamide nephrotoxicity in children]. Pol Merkur Lekarski (2003) 0.75
[The influence of systemic blood pressure on renal function in children and adolescents with type 1 diabetes mellitus]. Pol Merkur Lekarski (2003) 0.75
[The role of insulin secretion and insulin resistance in the clinical course of newly diagnosed diabetes mellitus in children]. Med Wieku Rozwoj (2005) 0.75
[Soft tissue sarcoma of the bladder and prostate. A report of the Polish Paediatric Solid Tumour Group (PPSTG)]. Med Wieku Rozwoj (2005) 0.75
[Alleles of HLA-DQB1 and familial aggregation of type 1 diabetes]. Med Wieku Rozwoj (2003) 0.75
[Can children with Hodgkin's disease be treated with chemotherapy only?]. Przegl Lek (2010) 0.75
[Prognostic value of humoral and metabolic markers as an evaluation of risk for developing type 1 diabetes]. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw (2003) 0.75
[Iatrogenic hyperlipidemia after l-asparaginase and glucocorticoid treatment in two children with acute lymphoblastic leukemia]. Pol Merkur Lekarski (2003) 0.75
[Insulin resistance in newly diagnosed type 1 diabetic children and adolescents]. Med Wieku Rozwoj (2003) 0.75
[Rare tumours--are they really rare in the Polish children population?]. Przegl Lek (2004) 0.75
[Malignant vascular tumours in children -- report from the Polish Pediatric Rare Tumors Study]. Med Wieku Rozwoj (2005) 0.75
[Increased frequency of A-G transition at exon 5 of GSTP1 as a genetic risk factor for acute childhood leukaemia]. Med Wieku Rozwoj (2005) 0.75
[Severe hypoglycemia and insulin antibodies levels in children and adolescents with type 1 diabetes]. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw (2003) 0.75